Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Back to Industry News
General

Dagens industri: Zinzino's Revenue Jumps 48% in Q3 2025

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Dagens industri

Key takeaways

  • According to Dagens Industri, Zinzino AB reported a substantial increase in revenue for the third quarter of 2025
  • Total revenue reached 786
  • 7 million SEK, a 48% increase compared to 532
According to Dagens Industri, Zinzino AB reported a substantial increase in revenue for the third quarter of 2025. Total revenue reached 786.7 million SEK, a 48% increase compared to 532.8 million SEK in the same period of the previous year. This growth was primarily fueled by a 54% increase in sales market revenue, contributing 777.3 million SEK to the quarterly total. September 2025 also demonstrated strong performance, with revenues increasing by 50% year-over-year to 277.2 million SEK. Sales markets generated 273.5 million SEK, representing a 53% increase compared to September 2024. Conversely, external sales from Faun Pharma declined to 3.7 million SEK, a decrease from 5.8 million SEK in the prior year. For the first nine months of 2025, Zinzino's cumulative sales rose by 54% to 2,304.9 million SEK, up from 1,494.3 million SEK during the same period in 2024. Regionally, the Asia-Pacific market exhibited the most significant growth in Q3, with revenues increasing by 186% to 63.7 million SEK. North America followed, with a 147% increase to 129.8 million SEK. Central Europe, a key market for Zinzino, experienced a 75% growth, reaching 242.8 million SEK. Other regions posting positive Q3 growth included Africa (+46%), South & West Europe (+32%), the Baltics (+31%), the Nordic region (+10%), and Eastern Europe (+2%). Throughout the January-to-September period, Asia-Pacific and North America continued to lead growth, with rates of 348% and 185%, respectively. Eastern Europe was the only region to experience a slight year-to-date sales decline of 1%.

Related Topics

Zinzinorevenue growthsales marketsAsia-PacificNorth Americahealth and wellnessfinancial results

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original